What the agency is buying
by RFPFinder from the notice; the solicitation governsThe Federal agency is seeking to expand the Production Assistance for Cellular Therapy (PACT) III program. This presolicitation aims to re-introduce the manufacture and distribution of cellular products for human clinical trials.
Scope
- Manufacture and distribution of cellular products
- For human subjects in clinical trials under IND applications
1 signal behind this label (incumbent, repeat winner, short window, brand-name or sole-source language, prior sources sought). Pro shows them with sources.
From USAspending awards and the notice text, recomputed nightly (Oct 8). A signal, not a verdict.
How to get the bid documents
- Open the notice on SAM.gov
- Download the 1 attachment listed below from the source
- Submit before the deadline
Details
- Place of performance
- Not stated
- Buyer type
- Federal
- Notice type
- Presolicitation
- Solicitation no.
- 75N920-18-R-0070
- Local presence
- Not required
- Amendments
- 2, last Oct 7
- Contact
- Williams, Jeffrey A.
Not stated in the notice: estimated value, contract type, period of performance. Check the bid documents.
Contact details from the source notice. Contact the buyer only about this solicitation.
Key dates
- Amendment 1
- Thu, Aug 9, 2018
- Amendment 2
- Wed, Oct 7, 2026 · The scope of the PACT III program has been expanded to include the manufacture and distribution of cellular products for use in human subjects participating in clinical trials.
Change log
verified Fri, Oct 9 · 12:30 AM ET- Posted · PresolicitationFri, Aug 3, 2018 · 10:06 AM ET
- Amendment · New version of the notice posted at the sourceThu, Aug 9, 2018 · 1:12 PM ET
- Amendment · The scope of the PACT III program has been expanded to include the manufacture and distribution of cellular products for use in human subjects participating in clinical trials.Wed, Oct 7, 2026 · 12:35 AM ET
- Updated · description text changedThu, Oct 8, 2026 · 12:38 AM ET
- Updated · description text changedFri, Oct 9, 2026 · 12:33 AM ET
Report a problem
Notice as published
A--to expand the scope of the program by re-introducing the manufacture and distri
The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by re-introducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.
Similar federal awards · NAICS 541715
USAspending.gov, last 36 months4 awards matched · tier 3: NAICS 541715 at any agency; nothing from this office or agency. Most recent:
Pro shows every award with the recipient, amount, period and a link to the award record, plus a CSV export. $39/mo.
Sign in or upgradeAwards for this key have not been synced yet.
Similar open RFPs
same NAICS 541715Listing collected from SAM.gov. Always confirm requirements in the original solicitation before you bid.